EU Regulators Warn of Counterfeit Copies of Cancer Drug Herceptin
EU regulators have issued a warning that several batches of the cancer medicine Herceptin (trastuzumab) have been “tampered with,” falsified and reintroduced into the supply chain, potentially putting patients at risk.
High-cost cancer medications like Herceptin have become an increasingly tempting target for thieves and counterfeiters in recent years. While they lack the ready market that some drugs like Viagra have, their extraordinary cost means extraordinary paydays. US officials warned of a similar scare in February 2012, when counterfeit copies of Roche’s Avastin (bevacizumab) were found to have infiltrated the US supply chain. Another batch of the counterfeit drug was found in April 2012.
In the wake of those findings, FDA went after more than a dozen physicians, who were blamed for purchasing the Avastin from unauthorized suppliers in the pursuit of higher profit margins.
Related Posts
China has seized 31 million fake face masks amid crisis
BEIJING: China's crisis has sparked a thriving black market in fake medical...
Haiti – Economy : Haiti, paradise of smuggling
Because of the incompetence of the Government of Haiti to collect its taxes and...
Chop Chop – Illegal tobacco issue worsening
The importation and sale of illegally imported tobacco is a worsening problem in...
Foreign vs. local tobacco in the Middle East
Banner Icon HEALTH Tobacco consumption in the region is notoriously high. Smoking...